MERGIME IMERI: Open Payments
NPI 1215649025 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 15 payments from 6 companies in 2025. Trend: 2023 $533 · 2024 $959 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $177 |
| Sequel Med Tech, LLC | 2 | $175 |
| Xeris Pharmaceuticals, Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
Products named: MINIMED 780G, JARDIANCE, TWIIST, GVOKE HYPOPEN, Ozempic, Yorvipath.
Industry payments across MI — which companies pay providers there.
